Search
+
    SEARCHED FOR:

    CONCORD BIOTECH LTD Q1 RESULTS

    Q2 results today: Vodafone Idea, Eicher Motors among 650 companies to announce earnings on Wednesday

    Vodafone Idea is expected to report a narrower consolidated loss for the second quarter, driven by revenue growth and improved ARPU. Analysts predict a loss between Rs 6300-6400 crore, with revenue rising 5% year-on-year. Subscriber base may decline, but ARPU is projected to reach Rs 156-159.

    Q2 results this week: Hyundai, Nykaa, Vodafone Idea among 2515 companies to announce earnings

    Over 2500 companies, including prominent names like ONGC, Hindalco, and Hero MotoCorp, are set to release their second-quarter earnings this week. Early reports suggest muted results, with analysts predicting the slowest growth in over four years due to a marginal 2% rise in Nifty earnings.

    Syngene International Q2 Results: Net profit drops 9% to Rs 106 crore

    Syngene International, the contract research and manufacturing services arm of Biocon reported a 9% year-on-year (YoY) drop in net profit to Rs.106 crore in Q2FY25.

    Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain

    Biocon's net profit for Q1FY25 surged to ₹660 crore, up from ₹101 crore the previous year, primarily due to a one-time gain from selling Biocon Biologics' domestic branded formulation business. Revenue remained flat at ₹3,433 crore. Core EBITDA saw a decline, although overall EBITDA improved significantly due to the one-off gain.

    Mankind trumps EQT-ADIA to buy BSV for $1.67 bn

    This is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the deal is likely by this week.

    Syngene Q1 Results: Net profit drops 19% to Rs 76 crore

    Syngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit to Rs.76 crore in Q1FY25 led by discovery services revenue taking a hit due to funding constraints at US biotechs.

    The Economic Times
    BACK TO TOP
      翻译: